Compare SOPH & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOPH | TOI |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 346.3M |
| IPO Year | 2021 | N/A |
| Metric | SOPH | TOI |
|---|---|---|
| Price | $4.96 | $4.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $7.00 | $6.00 |
| AVG Volume (30 Days) | 56.8K | ★ 1.7M |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $73,297,000.00 | ★ $461,039,000.00 |
| Revenue This Year | $18.32 | $28.51 |
| Revenue Next Year | $15.61 | $23.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.66 | ★ 21.67 |
| 52 Week Low | $2.58 | $0.25 |
| 52 Week High | $5.30 | $4.88 |
| Indicator | SOPH | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 59.24 | 66.49 |
| Support Level | $4.52 | $3.41 |
| Resistance Level | $4.82 | $4.29 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 87.27 | 87.74 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.